Skip to main content
. 2015 Nov 6;2015(11):CD008984. doi: 10.1002/14651858.CD008984.pub2

ENIGMA trial 2007.

Methods Multi‐centre RCT
Participants Setting: 19 hospitals from 6 countries
Inclusion criteria: patients were aged 18 years or older, were scheduled to undergo general anaesthesia for surgery that included a skin incision and that was anticipated to exceed 2 h, and were expected to be in the hospital for at least 3 days after surgery
Exclusion criteria: patients undergoing cardiac surgery, or thoracic surgery requiring one‐lung ventilation; patients that the anaesthesiologist considered that nitrous oxide was contraindicated (e.g. a history of post‐operative emesis or if the anaesthesiologist wanted to use supplemental oxygen for colorectal surgery)
Participant numbers: 2050 randomly assigned; 2012 analysed
Interventions Intervention: patients were administered a gas mixture of 70% nitrous oxide with 30% oxygen after induction of anaesthesia and until completion of surgery.
 Control: patients were administered a gas mixture of 80% oxygen with 20% nitrogen after induction of anaesthesia and until completion of surgery.
Outcomes Primary outcomes:
Inhospital case fatality rate
Secondary outcomes:
Pneumonia: radiologic infiltrate confirmed by chest x‐ray or computed tomography, in association with at least one of the following: temperature greater than 38°C, leukocyte count greater than 12,000/mL, or positive sputum culture that was not heavily contaminated with oral flora or that corresponded with positive blood cultures
Pulmonary atelectasis: confirmed by chest x‐ray or computed tomography
Myocardial infarction: confirmed by ECG and/or troponin or CK‐MB enzyme rise
Stroke: a new neurological deficit persisting for 24 hours, confirmed by neurologist assessment and/or computed tomography scan or magnetic resonance imaging
Severe nausea and vomiting: at least 2 episodes > 6 hrs apart, or if requiring > 2 doses of antiemetic medication
Venous thromboembolism: symptomatic deep venous thrombosis, confirmed by venography, duplex ultrasonography, V‐Q scan or spiral computed tomography, or autopsy
Wound infection: if associated with purulent discharge or a positive microbial culture
Length of hospital stay
Length of ICU stay
Notes ClinicalTrials.gov identifier: NCT00164047
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "Patients were randomly assigned using a computer‐generated code."
Allocation concealment (selection bias) Low risk Quote: "The random sequence was accessed via an automated telephone voice recognition service."
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: "All research staff, including those responsible for postoperative data collection and outcome assessment, were precluded by protocol from accessing the anaesthetic record and so were blinded to group identity."
Blinding of outcome assessment (detection bias) 
 Inhospital case fatality rate/length of stay Low risk Quote: "All research staff, including those responsible for postoperative data collection and outcome assessment, were precluded by protocol from accessing the anaesthetic record and so were blinded to group identity."
Blinding of outcome assessment (detection bias) 
 Complications Low risk Quote: "All research staff, including those responsible for postoperative data collection and outcome assessment, were precluded by protocol from accessing the anaesthetic record and so were blinded to group identity."
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
Selective reporting (reporting bias) Low risk Protocol was registered as NCT00164047 and outcomes were reported.
Other bias Low risk No other potential sources of bias were detected.